Last month, the Future Health Report was presented at the World Health Assembly in Geneva, Switzerland. The report states ...

A fresh attempt to bring more pharmaceutical manufacturing back to US soil has put the sector on alert, as a new executive ...

Oxford, UK-based biotech SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease ...

New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, closed Monday’s trading nearly ...

Privately-owned German biotech XL-protein GmbH today announced that it has entered into a worldwide license, development and ...

UK privately-held T-regulatory (Treg) cell therapies developer Quell Therapeutics today revealed that pharma major ...

UK-based microbiome company Microbiotica has appointed Robert Tansley its chief medical officer (CMO).

German science and technology firm Merck KGaA (MRK: DE) has moved a step closer to introducing a new therapy for tenosynovial ...

Africa is grappling with a worsening mpox crisis, with a critical shortfall of vaccine doses threatening to derail ...

Following global reports of serious adverse events in older people, the government’s independent expert advisory body, the UK ...

US Health Secretary Robert F Kennedy Jr has removed all 17 members of a key vaccine advisory committee, a move officials say ...

Dutch late-stage biotech NewAmsterdam Pharma (Nasdaq: NAMS) late yesterday announced positive top-line data from prespecified ...